Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1171-1176

  Rager, Kelly J ^a   Langland, Jeffrey O ^b   Jacobs, Bertram L ^b   Proud, David ^a   Marsh, David G ^a   Imani, Farhad ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN SUBCLASS; PROTEIN KINASE;

ALLERGY; ARTICLE; ASTHMA; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS INFECTION;

EID: 0031930767     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1171-1176.1998     Document Type: Article

References (41)

1. Beattie, E., K. L. Denzler, J. Tartaglia, M. E. Perkus, E. Paoletti, and B. L. Jacobs. 1995. Reversal of the Interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:499-505.
2. Brand, S. R., R. Kobayashi, and M. B. Mathews. 1997. The Tat protein of human immunodeficiency virus type 1 is a substrate and an inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272:8388-8395.
3. Burrows, B., M. R. Sears, E. M. Flannery, G. P. Herbison, and M. D. Holdaway. 1992. Relationships of bronchial responsivencss assessed by methacholine to serum IgE, lung function, symptoms, and diagnoses in 11-year-old New Zealand children. J. Allergy Clin. Immunol. 90:376-385.
4. Chang, H-W., J. C. Watson, and B. L. Jacobs. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89: 4825-4829.
5. Delphin, S., and J. Stavnezer. 1995. Characterization of an interleukin 4 (IL 4) responsive region in the immunoglobulin heavy chain germline ε promotor: regulation by NF-IL4, a C/EBP family member and NF-κB/p50. J. Exp. Med. 181:181-192.
6. Frick, O. L. and D. L. Brooks. 1984. Immunoglobulin E antibodies to pollens augmented in dogs by virus vaccines. Am. J. Vet. Res. 44:440-443.
7. Frick O. L., D. F. German, and J. Mills. 1979. Development of allergy in children: association with virus infections. J. Allergy Clin. Immunol. 63:228-241.
8. Gauchat, J.-F., D. A. Lebman, R. L. Coffman, H. Gascan, and J. E. de Vries. 1990 Structure and expression of germline epsilon transcripts ini human B cells induced by interleukin-4 to switch to IgE production. J. Exp. Med. 172:463.
9. Gribaudo, G., D. Lembo, G. Cavallo, S. Landolfo, and P. Lengyel. 1991. Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65:1748-1757.
10. Griffin, D. E., S. J. Cooper, R. L. Hirsch, R. T. Johnson, I. L. de Seriano, S. Roedenbeck, and A. Vaisberg. 1985. Changes in plasma IgE levels during complicated and uncomplicated measles virus infection. J. Allergy Clin. Immunol. 76:206-213.
11. Grilli, M., J. J.-S. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel. participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
12. Imani, F., and B. L. Jacobs. 1988. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA 85:7887-7891.
13. Ishizaka, T., H. Tomioka, and K. Ishizaka. 1971. Degranulation of human basophil leukocytes by anti-gamma E antibody. J. Immunol. 106:705-710.
14. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat-6 is required for mediating responses to IL-4 and tor development of Th2 cells. Immunity 4:313-319.
15. Katze, M. G., D. DeCorato, B. Safer, and A. G. Hovanessian. 1987. Adenovirus VAI RNA complexes with the 68,000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J. 6:689-697.
16. Koliais, S. I. 1981. Presence of double-stranded regions ot viral RNA in infected cells. Experientia 37:971-972.
17. Konieczny A., and B. Safer. 1983. Puritication of the eukaryotic initiation factor 2-eukaryolic initiation factor 2B complex and characterization of its guanine nucleotide exchange activity during protein synthesis initiation. J. Biol. Chem. 258:3402-3408.
18. Kumar, A., J. Haque, J. Lacoste, J. Hiscott, and B. G. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA 91:6288-6292.
19. Lebleu B., G. C. Sen, S. Shaila, B. Cabrer, and P. Lengyel. 1976. Interferon, double-stranded RNA, and protein phosphorylation. Proc. Natl. Acad. Sci. USA 73:3107-3111.
20. Lebrec, H., K. Sarlo, and G. R. Burleson. 1996. Effect of influenza virus infection on ovalbumin-specific IgE responses to inhaled antigen in the rat. J. Toxicol. Environ. Health 49:619-630.
21. Leibovitz, E., J. Freihorst, P. A. Piedra, and P. L. Ogra. 1988. Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus: implication in virally induced allergy. Int. Arch. Allergy Appl. Immunol. 86:112-116.
22. Lenardo, M. J., C.-M. Fan, T. Maniatis, and D. Baltimore. 1989. The involvement of NF-κB in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287-294.
23. Levy, D. A., and A. G. Osler. 1966. Studies on the mechanisms of hypersensitiviry phenomena. XIV. Passive sensitization in vitro of human leukocytes to ragweed pollen antigen. J. Immunol. 97:203-212.
24. Lin, R., D. Gewert, and J. Hiscott. 1995. Differential transcription activation in vitro by NFκB/Rel proteins. J. Biol. Chem. 270:3123-3131.
25. Lin, R. Y., and J. K. Smith, Jr. 1988. Hyper-IgE and human immunodeficiency virus infection. Ann. Allergy 61:269-272.
26. Lu, Y., R. M. Wambach, and R. M. Krug. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214:222-228.
27. Maitra, R. K., N. A. McMillan, S. Desai, J. McSwiggen, A. G. Hovanessian, G. Sen, B. R. Williams, and R. H. Silverman. 1994. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204:823-827.
28. Minks, M. A., D. K. West, S. Benvin, and C. Baglioni. 1979. Structural requirements of double-stranded RNA for the activation of 2′-5′ oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem. 254:10180-10183.
29. Miyamoto, N. G., B. L. Jacobs, and C. E. Samuel. 1983. Mechanism of interferon action. Effect of double-stranded RNA and the 5′-O-monophosphate form of 2′,5′-oligoadenylate on the inhibition of reovirus mRNA translation in vitro. J. Biol. Chem. 258:15232-15237.
30. Nielsch, U., S. G. Zimmer, and L. E. Babiss. 1991. Changes in NF-κB and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5-versus Ad12-transformcd cells. EMBO J. 10:4169-4175.
31. pro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2. J. Virol. 63:5069-5075.
32. Rice, A. P., R. Duncan, J. W. B. Hershey, and I. M. Kerr. 1985. Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells. J. Virol. 54:894-898.
33. Rothman, P., S. C. Li, B. Gorham, L. Glimcher, F. Alt, and M. Boothby. 1991. Identification of a conserved lipopolysaccharide-plus-interleukm-4-responsive element located at the promoter of germ line ε transcripts. Mol. Cell. Biol. 11:5551-5561.
34. Rothman, P., S. Lutzker, W. Cook, R. Coffman, and F. W. Alt. 1988. Mitogen plus interleukin 4 induction of C epsilon transcripts in B lymphoid cells. J. Exp. Med. 168:2385-2389.
35. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
36. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
37. Sha, W. C., H.-C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
38. Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79-146.
39. Visvanathan, K. V., and S. Goodbourn. 1989. Double-stranded RNA activates binding of NF-κB to an inducible element in the human beta-interferon promoter. EMBO J. 8:1129-1138.
40. Whitaker-Dowling, P., and J. S. Youngner. 1983. Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity. Virology 131:128-136.
41. Zilberstein, A., P. Federman, L. Shulman, and M. Revel. 1976. Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells. FEBS Lett. 68:119-124.